Schroder Adveq
Investor profile
Angel
Schroder Adveq has backed 2 European tech companies across 2 funding rounds between 2021 and 2022, joining rounds totalling €121M. Most active in Fintech and Cybersecurity. Data as of 4 Nov 2026.
Deals
2
distinct rounds
Companies
2
backed
Active span
2021–2022
2 yrs
Total round €
€121M
sum of rounds joined
Deals by year
distinct rounds / yearSchroder Adveq — deals by year — interactive chart.
Data table
| Schroder Adveq — deals by year | |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
Top sectors
by dealsSchroder Adveq — top sectors — interactive chart.
Data table
| Schroder Adveq — top sectors | |
|---|---|
| Fintech | 1 |
| Cybersecurity | 1 |
| Healthtech | 1 |
Stages
by dealsSchroder Adveq — stages — interactive chart.
Data table
| Schroder Adveq — stages | |
|---|---|
| Series B | 1 |
| Series C | 1 |
Countries
by dealsSchroder Adveq — countries — interactive chart.
Data table
| Schroder Adveq — countries | |
|---|---|
| Switzerland | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Immunos Therapeutics | Switzerland | 1 | €68M |
| Tessian | UK | 1 | €53M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Immunos Therapeutics | Series B | €68M | 2022-06 |
| Tessian | Series C | €53M | 2021-05 |